<html>
<head>PUBMED IDs for ANKS1A</head>
<body bgcolor='#C5F0F2'><h1>ANKS1A</h1><a href='https://pubmed.ncbi.nlm.nih.gov/21081186/'>The interactome of a PTB domain-containing adapter protein, Odin, revealed by SILAC.</a> May 3  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/23144319/'>Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.</a> April 4  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23825523/'>Odin (ANKS1A) modulates EGF receptor recycling and stability.</a> January 15  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/26698571/'>ANKS1B Interacts with the Cerebral Cavernous Malformation Protein-1 and Controls Endothelial Permeability but Not Sprouting Angiogenesis.</a> July 20  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26698569/'>MTA1-upregulated EpCAM is associated with metastatic behaviors and poor prognosis in lung cancer.</a> September 8  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/28108556/'>Confirmation of five novel susceptibility loci for systemic lupus erythematosus (SLE) and integrated network analysis of 82 SLE susceptibility loci.</a> January 22  2017<br></body></html>
